Is the Options Market Predicting a Spike in Merit Medical Systems Stock?
Investors need to pay close attention to MMSI stock based on the movements in the options market lately.
Zacks
More News
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
MMSI leans on therapeutic strength, an oncology acquisition and a new stent launch, but tariffs, OEM weakness and China pressure shadow 2026.
Zacks
The Cooper Companies Gears Up to Post Q2 Earnings: What's in Store?
CooperVision momentum and MyDay/MiSight adoption are likely to fuel COO's Q2, but Japan softness and fertility uncertainty remain key watch points.
Zacks
Here's Why Merit Medical (MMSI) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?
Key PointsDirector Lynne Ward sold 5,000 shares on May 7, 2026 for a transaction value of ~$313,000 at around $62.61 per share...
Nasdaq News: Markets
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Merit Medical Systems (NASDAQ:MMSI) Reaches New 12-Month Low Following Analyst Downgrade
Merit Medical Systems (NASDAQ:MMSI) Reaches New 12-Month Low After Analyst Downgrade...
MarketBeat
Merit Medical Systems (NASDAQ:MMSI) Given New $85.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group decreased their price target on shares of Merit Medical Systems from $90.00 to $85.00 and set a "buy" rating for the company in a research report on Friday...
MarketBeat
JPMorgan Chase & Co. Cuts Merit Medical Systems (NASDAQ:MMSI) Price Target to $77.00
JPMorgan Chase & Co. dropped their price target on Merit Medical Systems from $95.00 to $77.00 and set an "overweight" rating for the company in a research report on Friday...